Change in Elekta’s Nomination Committee for the Annual General Meeting 2026

Anna Magnusson has replaced Thomas Wuolikainen as the Fourth Swedish National Pension Fund’s appointed representative on the Nomination Committee.

Following this change, Elekta’s Nomination Committee comprises:

• Laurent Leksell (Chair of the Nomination Committee), in his capacity as Chair of the Board of Elekta and representing his own and related parties’ holdings
• Anna Magnusson, appointed by the Fourth Swedish National Pension Fund
• Katarina Hammar, appointed by Nordea Funds
• Elisabet Jamal Bergström, appointed by SEB Funds
• Robin Nestor, appointed by Lannebo Kapitalförvaltning

Shareholders wishing to submit proposals to Elekta’s Nomination Committee can do so by e-mail to [email protected] or by letter to:

Elekta AB (publ)
Att: Nomination Committee
P.O. Box 7593
SE-103 93 Stockholm
Sweden

In order for the Nomination Committee to be able to process any proposals constructively, these should be received by the Nomination Committee no later than June 5, 2026.

# # #

For further information, please contact:
Peter Nyquist, Head of Investor Relations
Tel: +46 70 575 2906, e-mail: [email protected]
Time zone: CET (Central European Time)

About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,500 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com.